Article
Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolism.
Endocrinology - 6 May 2026
Lee Hye Kyung, Pyatkov Maxim, Gavrilova Oksana, Liu Naili, Demby Tamar, Ye Bingtian, Furth Priscilla A, Hennighausen Lothar, Waxman David J
Abstract excerpt
Growth hormone (GH) signaling through signal transducer and activator of transcription 5 (STAT5B) is a central regulator of hepatic metabolism, yet the functional consequences of disease-associated STAT5B variants remain poorly understood. Here, we analyzed mice carrying STAT5BY665F (gain-of-function) and STAT5BY665H (loss-of-function) variants and dissect their impact on metabolic regulation. STAT5BY665F mice...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
